Mentorship Program
The Clinical TMS Society mentorship program is established for a six (6) month duration, but the mentor/mentee relationship can be extended beyond, if both parties are in agreement. This program is designed to be a forum to meaningfully connect mentees interested in expanding their TMS knowledge base and skills with experienced mentors who are willing to share their expertise for the purpose of supporting education, encouraging professional development, ensuring quality clinical standards, and increasing engagement of the CTMSS membership.
There are four different categories:
- Resident, Medical Student, Trainee
- Clinician Starting a New Practice
- TMS Coordinator/Technician
- TMS Research
Select your top three (3) mentors listed in the sections below and enter their names on your Mentee Application.
Resident, Medical Student, Trainee
| Mentor Name | Biography | Language(s) Spoken | Time Zone/Region | Availability |
| Rebecca Allen, MD, MPH | I completed residency at Harvard Longwood and Fellowship in Neuropsychiatry and Behavioral Neurology at Brigham and Women's Hospital. I have been practicing as an interventional psychiatrist offering TMS, ECT, and VNS since 2017, and we have added services over time, such that our clinics now offer Spravato, IV ketamine, and ketamine-assisted psychotherapy. I served as President of the Clinical TMS Society 2023-24, and am currently the Immediate Past President. I have served as Faculty at the CTMSS' PULSES course (topic: Beyond Depression) and been a speaker at two of CTMSS' Annual Meetings (2023: panel on the business of TMS; 2024: ask the experts panel). I am a Partner/owner (one of three) of a 60ish person company, Seattle Neuropsychiatric Treatment Center (SNTC), which has 5 clinics all offering TMS and Spravato; our two flagship clinics have our additional services (IVK, KAP, clinical trials). I am SNTC's Director of Research, and our clinical trials currently include two on TMS; our other trials are on psilocybin, VNS, a new device measuring brain oxygenation, and biomarkers of treatments response. | English | Pacific Time Zone, US | Every other week or monthly |
| Prasad Reddy, MD | I started TMS in 2011 with Neurostar. They say that I have done 2 million treatments; maybe they are counting the pulses or trains! Who knows? Now, I use Magstim, and we have about five patients on average every day. We practice in a rural area that is one of the poorest in the country. All of my patients are insured. We have only two cash-paying patients. We track every patient with PHQ 9, PTSD scales, Pain scales, and anxiety scales. | English | Pacific Time Zone, US | 1/week |
| Christina Hughes, MD | *Physical Medicine and Rehabilitation Physician with fellowship training in Multiple Sclerosis. *Involved with TMS since 2009 and TMS has been my clinical focus since 2016 *I am a Fellow of CTMSS *Currently on the Board of Directors for CTMSS, as well as on the membership/outreach committee and the training committee and am active in FACTMS. *My training in TMS includes the week-long Harvard TMS Course as well as the CTMSS Pulses Course and I hold certifications for Magventure, Brainsway, Magstim, and Neurostar machines. *I use all FDA approved protocols for TMS and off-label protocols on a case-by-case basis for depression and other neuropsychiatric disorders. *My husband, a psychiatrist, and I started one of the first few TMS clinics in the Seattle area in 2016. Since then, I have started an additional private practice TMS clinic in a rural area and have been a mentor to the clinical team who were awarded the first new FACTMS - Neil S. Hirsch free TMS clinic that opened this summer. *Currently serve as Medical Director for the Kitsap and Tacoma divisions of Seattle Neuropsychiatric Treatment Center. *My career has included both academics and private practice. |
English | Pacific Time, US | 1/week |
| Izio Klein, MD | Psychiatrist, Member of the Brazilian Psychiatric Association (ABP) and the Clinical TMS Society (CTMSS), certified in the use of Non-Invasive Neuromodulation techniques by the Institute of Psychiatry (Clinics Hospital - School of Medicine - USP - IPq-HCFMUSP). Assistant psychiatrist and researcher at the Institute of Psychiatry (Clinics Hospital- School of Medicine - USP - IPq-HCFMUSP), member of the Interdisciplinary Neuromodulation Service (SIN / EMT) and the Ketamine Service, preceptor of the Fellowship and the Specialization Course in Interventional Psychiatry (HCFMUSP). Psychiatrist on the clinical staff of the Albert Einstein Israelite Hospital (HIAE) and Head of the Neuromodulation Department at Soul Clinic (RJ). My main interests, in both clinical settings and in research, are the applications of neuromodulation techniques and the use of more invasive treatments and medications for treatment resistant disorders in psychiatry. |
Portuguese, English, Hebrew | GMT -3 (Brasilia) | 1/week |
Clinician Starting a New Practice
| Mentor Name | Biography | Language(s) Spoken | Time Zone/Region | Availability |
| Rebecca Allen, MD, MPH | I completed residency at Harvard Longwood and Fellowship in Neuropsychiatry and Behavioral Neurology at Brigham and Women's Hospital. I have been practicing as an interventional psychiatrist offering TMS, ECT, and VNS since 2017, and we have added services over time, such that our clinics now offer Spravato, IV ketamine, and ketamine-assisted psychotherapy. I served as President of the Clinical TMS Society 2023-24, and am currently the Immediate Past President. I have served as Faculty at the CTMSS' PULSES course (topic: Beyond Depression) and been a speaker at two of CTMSS' Annual Meetings (2023: panel on the business of TMS; 2024: ask the experts panel). I am a Partner/owner (one of three) of a 60ish person company, Seattle Neuropsychiatric Treatment Center (SNTC), which has 5 clinics all offering TMS and Spravato; our two flagship clinics have our additional services (IVK, KAP, clinical trials). I am SNTC's Director of Research, and our clinical trials currently include two on TMS; our other trials are on psilocybin, VNS, a new device measuring brain oxygenation, and biomarkers of treatments response. | English | Pacific Time Zone, US | Every other week or monthly |
| Prasad Reddy, MD | I started TMS in 2011 with Neurostar. They say that I have done 2 million treatments; maybe they are counting the pulses or trains! Who knows? Now, I use Magstim, and we have about five patients on average every day. We practice in a rural area that is one of the poorest in the country. All of my patients are insured. We have only two cash-paying patients. We track every patient with PHQ 9, PTSD scales, Pain scales, and anxiety scales. | English | Pacific Time Zone, US | 1/week |
| Christina Hughes, MD | *Physical Medicine and Rehabilitation Physician with fellowship training in Multiple Sclerosis. *Involved with TMS since 2009 and TMS has been my clinical focus since 2016 *I am a Fellow of CTMSS *Currently on the Board of Directors for CTMSS, as well as on the membership/outreach committee and the training committee and am active in FACTMS. *My training in TMS includes the week-long Harvard TMS Course as well as the CTMSS Pulses Course and I hold certifications for Magventure, Brainsway, Magstim, and Neurostar machines. *I use all FDA approved protocols for TMS and off-label protocols on a case-by-case basis for depression and other neuropsychiatric disorders. *My husband, a psychiatrist, and I started one of the first few TMS clinics in the Seattle area in 2016. Since then, I have started an additional private practice TMS clinic in a rural area and have been a mentor to the clinical team who were awarded the first new FACTMS - Neil S. Hirsch free TMS clinic that opened this summer. *Currently serve as Medical Director for the Kitsap and Tacoma divisions of Seattle Neuropsychiatric Treatment Center. *My career has included both academics and private practice. |
English | Pacific Time, US | 1/week |
| Izio Klein, MD | Psychiatrist, Member of the Brazilian Psychiatric Association (ABP) and the Clinical TMS Society (CTMSS), certified in the use of Non-Invasive Neuromodulation techniques by the Institute of Psychiatry (Clinics Hospital - School of Medicine - USP - IPq-HCFMUSP). Assistant psychiatrist and researcher at the Institute of Psychiatry (Clinics Hospital- School of Medicine - USP - IPq-HCFMUSP), member of the Interdisciplinary Neuromodulation Service (SIN / EMT) and the Ketamine Service, preceptor of the Fellowship and the Specialization Course in Interventional Psychiatry (HCFMUSP). Psychiatrist on the clinical staff of the Albert Einstein Israelite Hospital (HIAE) and Head of the Neuromodulation Department at Soul Clinic (RJ). My main interests, in both clinical settings and in research, are the applications of neuromodulation techniques and the use of more invasive treatments and medications for treatment resistant disorders in psychiatry. |
Portuguese, English, Hebrew | GMT -3 (Brasilia) | 1/week |
| David Ortiz, MD | Psychiatrist from the Department of Psychiatry of the Hospital. “Dr. José Eleuterio González” UANL 1. 2025 CTMSS Annual Meeting. Active member of the Mexican Society of Neuromodulation. Certified in Transcranial Magnetic Stimulation. (TMS) Neuromodulation by the Mexican Society of Neuromodulation. Certified in Transcranial Magnetic Stimulation (TMS) by International Clinical TMS Certification. Active member of the Clinical TMS Society. |
Spanish, English | UTC-6 (Mexico) | 2/month |
TMS Coordinator/Technician
| Mentor Name | Biography | Language(s) Spoken | Time Zone/Region | Availability |
| Samir Ibrahim, OAM, MBCHB, MPsych, FRANZCP |
*Practicing psychiatry since 1980 *Practicing TMS since 2007 *Co-Chair at CTMSS *MAC with Monarch Mental Health Group *Director of TMS in three different private hospitals in Melbourne, Australia. |
English, Arabic, French | Australia, East Standard Time | 1/month |
| Izio Klein, MD | Psychiatrist, Member of the Brazilian Psychiatric Association (ABP) and the Clinical TMS Society (CTMSS), certified in the use of Non-Invasive Neuromodulation techniques by the Institute of Psychiatry (Clinics Hospital - School of Medicine - USP - IPq-HCFMUSP). Assistant psychiatrist and researcher at the Institute of Psychiatry (Clinics Hospital- School of Medicine - USP - IPq-HCFMUSP), member of the Interdisciplinary Neuromodulation Service (SIN / EMT) and the Ketamine Service, preceptor of the Fellowship and the Specialization Course in Interventional Psychiatry (HCFMUSP). Psychiatrist on the clinical staff of the Albert Einstein Israelite Hospital (HIAE) and Head of the Neuromodulation Department at Soul Clinic (RJ). My main interests, in both clinical settings and in research, are the applications of neuromodulation techniques and the use of more invasive treatments and medications for treatment resistant disorders in psychiatry. |
Portuguese, English, Hebrew | GMT -3 (Brasilia) | 1/week |
TMS Research
| Mentor Name | Biography | Language(s) Spoken | Time Zone/Region | Availability |
The contents of the Clinical TMS Society (CTMSS) website, such as text, graphics, images, and other materials created by the CTMSS or obtained from CTMSS's licensors, and other materials contained on the CTMSS site (collectively, "Content") are for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the CTMSS website.
If you think you may have a medical emergency, call your doctor or 911 immediately. The CTMSS does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the website. Reliance on any information provided by the CTMSS, CTMSS staff, others appearing on the site at the invitation of the CTMSS, or other visitors to the site is solely at your own risk.
The contents of the Clinical TMS Society (CTMSS) website, such as text, graphics, images, and other materials created by the CTMSS or obtained from CTMSS's licensors, and other materials contained on the CTMSS site (collectively, "Content") are for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the CTMSS website.
If you think you may have a medical emergency, call your doctor or 911 immediately. The CTMSS does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the website. Reliance on any information provided by the CTMSS, CTMSS staff, others appearing on the site at the invitation of the CTMSS, or other visitors to the site is solely at your own risk.